Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $13.38M.
ENTERPRISE VALUE (EV)
$13.38M
Aytu BioPharma, Inc.
Market Cap
$22.43M
Enterprise Value (EV)
$13.38M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $22.43M | $13.38M |
| LeonaBio, Inc. (LONA)vs › | $22.64M | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.69M | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.84M | N/A |
| Modular Medical, Inc. (MODD)vs › | $19.64M | $16.00M |
| Actuate Therapeutics Inc (ACTU)vs › | $19.41M | $15.39M |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.46M | $27.19M |
| Cosmos Health Inc. (COSM)vs › | $18.98M | $33.15M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.87M | $18.72M |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.76M | $6.43M |
Market Cap
$22.43M
Total Debt
$17.25M
Cash
$26.31M
Enterprise Value
$13.38M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
